Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CN Aims to Ramp Up Support for Biomanufacturing Industry Innovation & Development During 15th 5-Yr Plan: NMPA
Recommend 70 Positive 108 Negative 36 |
||||
|
||||
|
China's National Medical Products Administration (NMPA) announced that it is poised to vigorously support the innovation and development of the biomanufacturing industry during the 15th Five-Year Plan. Specifically, the NMPA will closely monitor new target and mechanism drugs, AI-driven drug R&D, and frontier technology fields like cell and gene therapy this year. It will also expedite the process for drug market entry through four accelerated approval channels. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
